Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Oryzon Genomics Cash from Operations (Annual) : -2.659M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -2.659M |
| December 31, 2024 | -6.154M |
| December 31, 2023 | -0.6216M |
| December 31, 2022 | -1.942M |
| December 31, 2021 | -4.286M |
| December 31, 2020 | -5.492M |
| Date | Value |
|---|---|
| December 31, 2019 | -4.403M |
| December 31, 2018 | -0.7858M |
| December 31, 2017 | -5.310M |
| December 31, 2016 | -5.539M |
| December 31, 2015 | 0.5801M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Pharma Mar SA | 59.96M |
| Grifols SA | 1.182B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alkermes Plc | 520.75M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |